Biodiversity Lovers, Unite

Several months into the International Biodiversity Observation Year (IBOY), American mass media coverage of this worldwide initiative is virtually nonexistent. Major publications for general audiences and high-impact scientific journals have not run news or feature articles about a collaboration that involves 45 major projects embracing numerous countries, habitats, and species. Why the silence? Comments by prominent biologists suggest that the answer lies, at least in part, in the very nature o

Written bySteve Bunk
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

IBOY, an assembly under one banner of worldwide projects in basic science, informatics, and education (see "Year of Biodiversity"), faces communication challenges. The problem is that the all-embracing nature of biodiversity makes appreciation of it more difficult to grasp than that of biodiversity's products, such as particular plants or animals.

"We all recognize there's a major crisis in biodiversity," Princeton University associate professor of biology and IBOY steering committee member Andrew P. Dobson comments. Rather than belabor the current, rapid loss of species around the world, he offers comparisons between art and life forms. In both cases, he notes, rarity is an attribute that can confer value. Only about 60 works of the 17th century Dutch painter Jan Vermeer are known to exist, Dobson says. Each one is highly valued. Similarly, he continues, many of contemporary British artist Damien Hirst's works were purchased by collector Charles Saatchi, who then bid ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies